Goldman Sachs Group Inc. Buys New Stake in Oaktree Acquisition Corp. III Life Sciences $OACC

Key Points

• Goldman Sachs Group Inc. acquired 529,535 shares of Oaktree Acquisition Corp. III Life Sciences, valued at approximately $5,417,000, giving them a 2.36% stake in the company.
• Other institutional investors have also increased their stakes, with notable purchases from firms including DLD Asset Management LP and Driehaus Capital Management LLC, highlighting growing interest in the SPAC.
• Oaktree Acquisition Corp. III Life Sciences shares opened at $10.49, experiencing a 1-year low of $9.95 and a high of $10.85, indicating stable price performance within this range.

Goldman Sachs Group Inc. acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 529,535 shares of the company's stock, valued at approximately $5,417,000. Goldman Sachs Group Inc. owned about 2.36% of Oaktree Acquisition Corp. III Life Sciences at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the business. Toronto Dominion Bank purchased a new position in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter worth $14,355,000. Driehaus Capital Management LLC purchased a new stake in Oaktree Acquisition Corp. III Life Sciences in the first quarter worth about $9,180,000. Linden Advisors LP purchased a new stake in Oaktree Acquisition Corp. III Life Sciences in the first quarter worth about $6,120,000. Millennium Management LLC bought a new stake in Oaktree Acquisition Corp. III Life Sciences during the 1st quarter valued at $4,848,000. Finally, Ghisallo Capital Management LLC bought a new stake in Oaktree Acquisition Corp. III Life Sciences during the 1st quarter valued at $4,590,000.

Oaktree Acquisition Corp. III Life Sciences Stock Up 0.1%

NASDAQ OACC traded up $0.01 during midday trading on Friday, hitting $10.49. 81,141 shares of the company traded hands, compared to its average volume of 97,814. The company's 50-day simple moving average is $10.45 and its 200-day simple moving average is $10.37. Oaktree Acquisition Corp. III Life Sciences has a 52 week low of $9.95 and a 52 week high of $10.85.

Oaktree Acquisition Corp. III Life Sciences Profile

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.